Sense Expansion Sees the Opening of Second Site

5 th December 2017, Oxfordshire, UK. Sense Biodetection Limited (Sense) has today announced that it has opened a new development facility near Cambridge, UK. The new site will serve as the home to the company’s design, development and production activities under the leadership of Chief Development Officer, Ralph Lamble. The facility complements Sense’s existing molecular laboratory facilities near Oxford, UK, and provides the company with the infrastructure necessary to develop and commercialise its highly innovative clinical diagnostic products.

Sense Completes £508,000 Seed Investment Round Led by Mercia

8th June 2016. Oxfordshire, UK. Sense Biodetection Limited (Sense) has today announced that is has completed a c.£508,000 oversubscribed seed investment round headed by leading technology investor, Mercia Fund Management. The investment will allow Sense to continue to establish its technology portfolio and support the further development and clinical evaluation of its first products.